News
-
New publication: "Cannabis" – A Handbook for Science and Practice
-
Authorisations of human medicinal products with a new active substance and additional indications 2023
-
Launch of new HMA-EMA catalogues of real-world data sources and studies
-
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 February 2024
-
Decision 9C_135/2022 of 12 December 2023
-
Infections in Swiss hospitals are to be significantly reduced
-
Illegal imports of medicinal products: Erectile stimulants account for more than two-thirds
-
Progress update on pilot for academic and non-profit developers of advanced therapy medicines
-
Swissmedic Journal 01/2024
-
Improving Addiction Support and Care Urgently Needed
-
Clinical trials' transition to new EU system - one year left
-
The European Medicines Agency (EMA) to support establishment of the African Medicines Agency
-
Precautionary measures to address potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines
-
Elisabeth Baume-Schneider at OECD Health Ministerial Meeting in Paris
-
Organ donation figures for 2023 in Switzerland reach a new record high
-
Major update of the user guide for micro, small and medium sizes enterprises (SMEs)
-
Stepping into the future: A closer look at the third revision of the Therapeutic Products Act (TPA)
-
Quality information on healthcare – how can a platform with added value for the public succeed?
-
Guidance document Authorisation according to Art. 14 para. 1 abis-quater of the Therapeutic Products Act (TPA) updated
-
Authorisation of immunological veterinary medicinal products in the event of an epizootic outbreak
-
Changes to the Guidance document Fast-track authorization procedure